General MedicationsTOPICALGeneric
E-SOLVE 2
ERYTHROMYCIN
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview E-SOLVE 2 is listed in Drugs@FDA under application 062467 (ANDA).
Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength LOTION;TOPICAL - 2% Sponsor SYOSSET Submission history Latest submission status date: 1991-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview E-SOLVE 2 is listed in Drugs@FDA under application 062467 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength LOTION;TOPICAL - 2% Sponsor SYOSSET Submission history Latest submission status date: 1991-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.